- Abstract
- Keywords
- Introduction
- Chemistry of BD
- Antineoplastic effects of BD in human malignancies
- Anti-metastatic effects of BD
- Potential anti-inflammatory effects of BD
- Pharmacokinetics, toxicity and metabolism
- Clinical application of BD
- Conclusion and future directions
- Abbreviations
- Declarations
- References
-
Citing Article List
The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Allosteric cross-talk between the hydrophobic cleft and the BH4 domain of Bcl-2 in control of inositol 1,4,5-trisphosphate receptor activity”.No. Publication Date Citing Article 1 2022 Nicolas Rosa, Femke Speelman-Rooms, Jan B. Parys, Geert Bultynck. Modulation of Ca2+ signaling by antiapoptotic Bcl-2 versus Bcl-xL: From molecular mechanisms to relevance for cancer cell survival, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2022; 1877: 188791188791. https://doi.org/10.1016/j.bbcan.2022.188791 2 2025 Wenxin Zhang, Xiaohui Pan, Longsheng Wang, Wen Li, Xiaoyang Dai, Mingming Zheng, Hongjie Guo, Xi Chen, Yanjun Xu, Honghai Wu, Qiaojun He, Bo Yang, Ling Ding. Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA release, Journal for ImmunoTherapy of Cancer. 2025; 13: e010889. https://doi.org/10.1136/jitc-2024-010889 -
